Anbio Biotechnology Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Anbio Biotechnology (NNNN) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $18.31 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2025-04-28.
Financial Statements › Notes
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-04-28
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|
| 2022-12-31 | $18.31K 20-F · filed 2025-04-28 |